Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01593709 · ClinicalTrials.gov registry record

Volunteer Screening for Vaccine and Antivirals Clinical Trials

A clinical trial of Normal Physiology, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
359
Enrollment target
1
Study location

NCT01593709 is a study of Normal Physiology that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 359 participants, below the 1,278-participant average among 25 other Normal Physiology trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01593709, a study of Normal Physiology, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
359 participants
Enrollment target
1
Study location

Study Summary

Background: \- Vaccines and antiviral therapies are critical for preventing and treating viral diseases. Testing these vaccines and drugs often requires healthy volunteers. To ensure that volunteers are healthy and eligible to participate in these studies, they will be screened before the start of the study. This screening may involve a medical history, physical exam, and blood test. Other samples may also be collected. This study will help identify volunteers who are eligible to participate in vaccine or antiviral therapy trials. Objectives: \- To screen volunteers for clinical trials of vaccines or drugs to treat or prevent virus infections. Eligibility: \- Healthy volunteers at least 18 years of age. Design: * Screening may begin several months before the start of the clinical trial. Participants may come to the National Institutes of Health clinic one or more times. * Participants may be screened with a physical exam and medical history. Blood samples will be collected. Other samples may also be collected, including urine, nasal wash, nasal swab, or stool samples. All samples will be stored for reference by the study researchers....

Conditions Studied

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda

Trial Details

FieldValue
Enrollment Target 359 participants
Start Date 2012-11-27
Est. Completion 2021-07-21

What the Registry Record Tells You About NCT01593709

The ClinicalTrials.gov registry entry for NCT01593709 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 359 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,278-participant average among 25 other Normal Physiology trials with a reported enrollment target (72% lower). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Normal Physiology appearing as the primary indexed condition, and to 0 interventions.

NCT01593709 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT01593709 about?

NCT01593709 is a clinical study titled "Volunteer Screening for Vaccine and Antivirals Clinical Trials". Background: \- Vaccines and antiviral therapies are critical for preventing and treating viral diseases. Testing these vaccines and drugs often requires healthy volunteers. To ensure that volunteers are healthy and eligible to participate in these studies, they will be screened before the start of ...

What is the current status of trial NCT01593709?

This trial is currently completed. The enrollment target is 359 participants. The study started on 2012-11-27. Estimated completion is 2021-07-21.

What conditions does trial NCT01593709 study?

This clinical trial studies the following conditions: Normal Physiology.

Who is sponsoring clinical trial NCT01593709?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01593709 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Normal Physiology

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.